Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DXCM · against 1,372 other Healthcare companies
Ranked #1,099 of 1,373 · scores higher than 20% of peers · safety percentile 20
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 10–19, including DXCM · Click a bar to see the companies
Mainly because of its beta, debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | DXCM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.53× | 0.24× | 29% | 33% | |
| BetaLower is better · 1,320 reported | 1.48 | 0.53 | 11% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.73× | 2.62× | 34% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,095 | 1.2B USD | 20 | 75 | |
| 1,096 | 24M SEK (≈$2M) | 20 | 14 | |
| 1,097 | 168.6B INR (≈$2.0B) | 20 | 63 | |
| 1,098 | 508M EUR (≈$559M) | 20 | 21 | |
| 1,099 | 31.3B USD | 20 | 63 | |
| 1,100 | Unavailable | 20 | 17 | |
| 1,101 | 62.7B JPY (≈$426M) | 20 | 40 | |
| 1,102 | 13.3B USD | 20 | 59 | |
| 1,103 | 66.3B USD | 20 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score